These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14641515)

  • 1. Reduced jaw opening from paradoxical activity of mandibular elevator muscles treated with botulinum toxin.
    Bakke M; Werdelin LM; Dalager T; Fuglsang-Frederiksen A; Prytz S; Møller E
    Eur J Neurol; 2003 Nov; 10(6):695-9. PubMed ID: 14641515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A.
    Teive HA; Klüppel LE; Munhoz RP; Becker N; Müller PR; Werneck LC
    Arq Neuropsiquiatr; 2012 Jun; 70(6):407-9. PubMed ID: 22699536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oromandibular dystonia involving the lateral pterygoid muscles: four cases with different complexity.
    Møller E; Bakke M; Dalager T; Werdelin LM
    Mov Disord; 2007 Apr; 22(6):785-90. PubMed ID: 17290453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach.
    Moscovich M; Chen ZP; Rodriguez R
    J Clin Neurosci; 2015 Mar; 22(3):594-6. PubMed ID: 25541097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification and clinical characteristics of masticatory myospasm].
    Fu KY; Zhang W; Cao Y; Kang YF; Xie QF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):423-6. PubMed ID: 22931574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
    Tan EK; Jankovic J
    Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome.
    Dressler D; Wittstock M; Benecke R
    Eur Neurol; 2001; 45(4):287-8. PubMed ID: 11385272
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2006 Mar; 12(2):115-8. PubMed ID: 16271495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual position-sensitive jaw tremor responsive to botulinum toxin.
    Tarsy D; Ro SI
    Mov Disord; 2006 Feb; 21(2):277-8. PubMed ID: 16211606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oromandibular dystonia, mental distress and oro-facial dysfunction-A follow-up 8-10 years after start of treatment with botulinum toxin.
    Bakke M; Baram S; Dalager T; Biernat HB; Møller E
    J Oral Rehabil; 2019 May; 46(5):441-449. PubMed ID: 30664806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin treatment for upper airway collapse resulting from temporomandibular joint dislocation due to jaw-opening dystonia.
    Yoshida K; Iizuka T
    Cranio; 2006 Jul; 24(3):217-22. PubMed ID: 16933464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report.
    Vazquez-Delgado E; Okeson JP
    Cranio; 2004 Oct; 22(4):325-9. PubMed ID: 15532318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
    Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.